1. Home
  2. KVUE vs AXON Comparison

KVUE vs AXON Comparison

Compare KVUE & AXON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kenvue Inc.

KVUE

Kenvue Inc.

N/A

Current Price

$17.26

Market Cap

34.2B

ML Signal

N/A

Logo Axon Enterprise Inc.

AXON

Axon Enterprise Inc.

N/A

Current Price

$423.02

Market Cap

41.1B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
KVUE
AXON
Founded
2022
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Ordnance And Accessories
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
34.2B
41.1B
IPO Year
2023
2001

Fundamental Metrics

Financial Performance
Metric
KVUE
AXON
Price
$17.26
$423.02
Analyst Decision
Hold
Buy
Analyst Count
14
21
Target Price
$19.50
★ $704.11
AVG Volume (30 Days)
★ 22.6M
869.0K
Earning Date
11-02-2026
11-03-2026
Dividend Yield
★ 4.76%
N/A
EPS Growth
★ 40.74
N/A
EPS
0.48
★ 2.41
Revenue
★ $15,124,000,000.00
$2,779,536,000.00
Revenue This Year
$3.12
$33.29
Revenue Next Year
$2.38
$29.33
P/E Ratio
★ $37.53
$174.46
Revenue Growth
N/A
★ 33.47
52 Week Low
$14.02
$339.01
52 Week High
$20.13
$764.02

Technical Indicators

Market Signals
Indicator
KVUE
AXON
Relative Strength Index (RSI) 34.40 32.16
Support Level $17.01 $402.98
Resistance Level $17.88 $438.97
Average True Range (ATR) 0.26 18.97
MACD 0.00 -1.71
Stochastic Oscillator 1.92 3.72

Price Performance

Historical Comparison
KVUE
AXON

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

About AXON Axon Enterprise Inc.

Axon Enterprise Inc is building a public safety operating system by integrating a suite of hardware devices and cloud software solutions. The company's suite includes cloud-hosted digital evidence management solutions, TASER energy devices, drones and robotic security, and training solutions. Its operation comprises of two operating segments, Software and Services, and Connected Devices. The company generates the majority of its revenue from the Connected Devices segment, which is engaged in developing, manufacturing, and selling fully integrated hardware solutions such as conducted energy devices sold under the TASER brand, body cameras, fixed and in-car cameras, drone and counter-drone technologies, and a broad ecosystem of accessories, extended warranties and related hardware products.

Share on Social Networks: